EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Application of metagenomic next-generation sequencing in HIV-negative hematogenous disseminated tuberculosis

Lingxin Luo, Jvrong Zhan, Zhen Wang, Xianzhi Du, Na Li

Frontiers in Cellular and Infection Microbiology · 02.07.2026 · 16

DOI: 10.3389/fcimb.2026.1851741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 02.07.2026. Verfasst von Lingxin Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Metagenomics, Mycobacterium tuberculosis. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hematogenous disseminated tuberculosis (Hematogenous disseminated tuberculosis, HDTB) is a rare, critical form of tuberculosis with a high case fatality ratio and is uncommon in HIV-negative patients. Early recognition of this disease is difficult, and limitations of traditional testing methods often lead to delayed diagnosis. This study aims to investigate the value of metagenomic Next-Generation Sequencing (metagenomic Next-Generation Sequencing, mNGS), as a promising tool, in the diagnosis of hematogenous disseminated tuberculosis in HIV-negative (Human Immunodeficiency Virus, HIV) patients.

Methods

A retrospective analysis was conducted of the clinical data of 10 HIV-negative patients with hematogenous disseminated tuberculosis confirmed by mNGS.

Results

All patients had pre-existing diseases that could lead to impaired immune function. Common symptoms included hyperpyrexia, cough, and dyspnea, and 6 patients developed respiratory failure. C-reactive protein (C-reactive protein, CRP) and procalcitonin (procalcitonin, PCT) levels were both elevated, and PCT was markedly elevated in more than half of the patients, using 0.5 ng/mL as the cutoff value. Most patients had markedly elevated D-dimer levels accompanied by thrombotic events, including 3 patients with concomitant pulmonary embolism. Chest imaging showed patchy pulmonary opacities, and 2 patients had atypical bilateral pleural effusion; these nonspecific findings were easily confused with those of other diseases. Blood mNGS detected Mycobacterium tuberculosis within 2 to 3 days. According to the presence or absence of concomitant pulmonary tuberculosis, the patients were divided into the pulmonary tuberculosis subgroup (pulmonary tuberculosis subgroup, PTB) and the non-pulmonary tuberculosis subgroup (non-pulmonary tuberculosis subgroup, non-PTB). The oxygenation index was significantly lower in the pulmonary tuberculosis subgroup than in the non-pulmonary tuberculosis subgroup (P = 0.037). All cases of pulmonary embolism occurred in the pulmonary tuberculosis subgroup, but the difference was not statistically significant.

Conclusions

HIV-negative patients with hematogenously disseminated tuberculosis have atypical clinical manifestations and are prone to incorrect diagnosis. The application of mNGS helps shorten diagnostic delays and accelerate disease control, providing an effective supplementary diagnostic pathway when conventional testing methods cannot identify the pathogen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingMetagenomicsMycobacterium tuberculosisHumansRetrospective StudiesMaleFemaleAdultMiddle AgedC-Reactive ProteinProcalcitoninTuberculosis, ExtrapulmonaryFibrin Fibrinogen Degradation Products

Stichwörter der Autor:innen

HIV-negativediagnosishematogenous disseminated tuberculosismetagenomic next-generation sequencingtuberculosis

Substanzen

C-Reactive ProteinProcalcitoninFibrin Fibrinogen Degradation Productsfibrin fragment D

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Zitieren

APA

Luo, L., Zhan, J., Wang, Z., Du, X., & Li, N. (2026). Application of metagenomic next-generation sequencing in HIV-negative hematogenous disseminated tuberculosis. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1851741

Vancouver

Luo L, Zhan J, Wang Z, Du X, Li N. Application of metagenomic next-generation sequencing in HIV-negative hematogenous disseminated tuberculosis. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1851741

BibTeX
@article{Luo2026,
  author = {Luo, Lingxin and Zhan, Jvrong and Wang, Zhen and Du, Xianzhi and Li, Na},
  title = {Application of metagenomic next-generation sequencing in HIV-negative hematogenous disseminated tuberculosis},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1851741}
}
Kostenlos starten →